39 Participants NeededMy employer runs this trial

AlphaReturn System for Pulmonary Embolism

(APEX-Return Trial)

Recruiting at 3 trial locations
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Angiodynamics, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.
I have been diagnosed with a pulmonary embolism from a CTA scan.
I have had symptoms of a serious lung blood clot for 14 days or less.
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • AlphaReturn Blood Management System

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: AlphaVac MMA F1885 System and AlphaReturn Blood Management SystemExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Angiodynamics, Inc.

Lead Sponsor

Trials
27
Recruited
3,100+